---

	6/17/11	VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival
	6/15/11	Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
	1/06/10	VGX Animal Health's Growth Hormone Releasing Hormone Shows Advantages Compared to Current Growth Hormone Therapies Used in Pigs
	10/11/08	VGX Animal Health developing a DNA therapy for cancer
	10/7/08	VGX Animal Health announces the commercialization of its LifeTide® SW 5 GHRH gene therapy product for pigs in Australia
	8/25/08	Inovio announces the publication of pivotal data from its LifeTide® SW 5 studies, which led to the approval in Australia of the GHRH gene therapy product for pigs
	6/17/08	VGX Gene Therapy Technology Featured at the 90th Annual Endocrine Society Meeting
	5/22/08	Inovio announces publication in Molecular Therapy regarding the Company’s GHRH gene therapy product
	4/4/08	Preliminary Study Performed on New Laminitis Treatment Technique
	1/9/08	VGX Animal Health announces approval of LifeTide® SW 5 - World’s First and Only Approved DNA Therapy for Food Animals
	11/7/07	VGX Animal Health Announces Promotion of Kevin W. Rassas to President
	5/07	The Scientist: Gene Therapy for Fido
	5/31/07	Inovio Announces Formation of Animal Health Company
	5/21/07	BusinessWeek: Development to Watch - Inovio
	2/26/07	Inovio and ADViSYS Announce Merger Agreement: Creation of VGX Immune Therapeutics Division